Home NDC 58914-501 Canasa
Product NDC 58914-501
11-digit product format 589140501
Labeler code 58914
Product ID 58914-501_f6634219-3e94-4856-b896-67c3bd3b168d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Mesalamine
Dosage form SUPPOSITORY
Route RECTAL
Labeler Allergan, Inc.
Application NDA021252
Marketing category NDA
Marketing start 2001-01-05
Substance MESALAMINE
Active strength 1000 mg/1
Pharmacologic classes Aminosalicylate [EPC], Aminosalicylic Acids [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021252-001 CANASA MESALAMINE 500MG SUPPOSITORY / RECTAL 2001-01-05 N021252-002 CANASA MESALAMINE 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021252-002 AB
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N021252-002 8217083 2028-06-06 Drug product 2013-05-24 N021252-002 8436051 2028-06-06 Drug product 2013-05-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021252-001 CANASA 500MG SUPPOSITORY / RECTAL 2001-01-05 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021252-002 CANASA 1GM SUPPOSITORY / RECTAL AB RLD, RS 2004-11-05 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Observed Orange Book patent history# Patent history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021252-002 8217083 2028-06-06 Drug product 2013-05-24 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N021252-002 8436051 2028-06-06 Drug product 2013-05-24 782e0a99824c…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2019-12-13 00:20 UTC 2019-12 N021252-001 M-187 2019-09-02 74a2ff9319b5…2019-12-14 00:12 UTC 2019-12 N021252-001 M-187 2019-09-02 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021252-001 M-187 2019-09-02 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021252-001 M-187 2019-09-02 ea99ee380514…
Additional Listing Data#
Finished product Yes
Brand name base Canasa
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MESALAMINE 1000 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 4Q81I59GXC Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 248420 Internal RxNorm lookup 583257 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 58914-501-33 Canasa 3 in 1 BOX SUPPOSITORY 3 30 58914-501-42 Canasa 42 in 1 BOX SUPPOSITORY 42 30 58914-501-56 Canasa 30 in 1 BOX SUPPOSITORY 30 30
DailyMed Socrata Ingredients# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 58914-501 CANASA (MESALAMINE) SUPPOSITORY [ALLERGAN, INC.] 28 Current NDC, Legacy NDC, 3 package rows 20241211_89d91601-152b-4398-bebe-af1c023e9935.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 58914-501-33 58914050133 3 SUPPOSITORY in 1 BOX (58914-501-33) 3 suppository 2001-01-05 0000-00-00 Yes No Current 58914-501-42 58914050142 42 SUPPOSITORY in 1 BOX (58914-501-42) 42 suppository 2001-01-05 0000-00-00 No No Current 58914-501-56 58914050156 30 SUPPOSITORY in 1 BOX (58914-501-56) 30 suppository 2001-01-05 0000-00-00 No No Current